E Sun
Impact in
- Ophthalmology top 5%
- Ocular Oncology and Treatments
- Otorhinolaryngology top 10%
Papers in
- Co-authors
- James J. Goedert (2 shared papers)Thomas R. Fears (1 shared paper)Joanne Huang (1 shared paper)T. Jake Liang (1 shared paper)Mads Melbye (1 shared paper)Rochelle E. Curtis (1 shared paper)Xiaobin Jia (1 shared paper)Miguel García‐Guzmán (2 shared papers)
- Journals
- Annals of Oncology (2 papers)Heart Rhythm (1 paper)Journal of Clinical Oncology (1 paper)Anaesthesia and Intensive Care (1 paper)Journal of Virology (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
E Sun
12 papers receiving 354 citations
Peers
Comparison fields: 5 of 57
- Ophthalmology 116
- Otorhinolaryngology 28
- Hepatology 44
- Epidemiology 162
- Oncology 121
Countries citing papers authored by E Sun
This map shows the geographic impact of E Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Sun more than expected).
Fields of papers citing papers by E Sun
This network shows the impact of papers produced by E Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Sun. The network helps show where E Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside E Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 145 | |
| 2 | Epidemiology of squamous cell conjunctival cancer. | 1997 | 135 |
| 3 | Salivary gland cancer in the United States. | 1999 | 58 |
| 4 | 2008 | 8 | |
| 5 | [Two-dimensional zebrafish model combined with hyphenated chromatographic techniques for evaluation anti-osteoporosis activity of epimendin A and its metabolite baohuoside I]. | 2014 | 6 |
| 6 | 2017 | 5 | |
| 7 | 2019 | 5 | |
| 8 | 2019 | 4 | |
| 9 | 2019 | 3 | |
| 10 | 2012 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2019 | 1 | |
| 13 | 2025 | 0 |
About E Sun
E Sun is a scholar working on Oncology, Surgery, Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 13 papers that have together received 372 indexed citations. Recurring topics across this work include Salivary Gland Tumors Diagnosis and Treatment (2 papers), Photodynamic Therapy Research Studies (2 papers), Nanoplatforms for cancer theranostics (1 paper), Vascular Tumors and Angiosarcomas (1 paper), Economic and Financial Impacts of Cancer (1 paper), Inflammatory Biomarkers in Disease Prognosis (1 paper), AI in cancer detection (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Ophthalmology (116 citations), Otorhinolaryngology (28 citations), Hepatology (44 citations), Epidemiology (162 citations) and Oncology (121 citations). E Sun has collaborated with scholars based in United States and China. Frequent co-authors include James J. Goedert, Thomas R. Fears, Joanne Huang, T. Jake Liang, Mads Melbye, Rochelle E. Curtis, Xiaobin Jia, Miguel García‐Guzmán, Jerry J. Fong and Richard H. Epstein. Their work appears in journals such as Annals of Oncology, Heart Rhythm, Journal of Clinical Oncology, Anaesthesia and Intensive Care and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.